Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Control system for shifting an automatic transmission
Data encoding and decoding apparatus and method thereof for verifying data integrity
Wind driven generator for vehicles
Memory device and self interleaving method thereof
Electrode tab for secondary battery and secondary battery using the same
Device and method for adjusting a chrominance signal based on an edge strength
Multi-dimensional tuple support in rule engines
  Randomly Featured Patents
Prioritization of microprocessors in multiprocessor computer systems
Mesoporous carbons
Techniques for clustering a set of objects
Angle pattern control valve
Failure diagnosis method, failure diagnosis apparatus, conveyance device, image forming apparatus, program, and storage medium
Coextruded thermoplastic stretch-wrap
Dissolvable gel capsule
Heparin compositions and methods of making and using the same
Three dimensional, position observation method and apparatus
Transmission system